Literature DB >> 18691072

Haptoglobin polymorphism and lacunar stroke.

Julie Staals1, Barbe M A Pieters, Iris L H Knottnerus, Rob P W Rouhl, Robert J van Oostenbrugge, Joris R Delanghe, Jan Lodder.   

Abstract

Haptoglobin (Hp) 2-2 phenotype has been associated with peripheral and coronary artery disease and risk of vascular complications in diabetic patients, but any association of Hp polymorphism with cerebrovascular disease has not been explored so far. We aimed to study Hp polymorphism in a sample of 124 patients with a rather homogeneous type of cerebrovascular disease, namely first symptomatic lacunar stroke due to small vessel disease, in comparison with a large (n=918) control group. Hp phenotypes were determined using starch gel electrophoresis. Hp1 allele frequency was significantly higher in patients than in controls (0.480 vs. 0.395, p<0.05), mainly due to a lower Hp2-2 phenotype frequency (25.0 vs. 36.3 %; OR 0.59; 95%CI 0.38-0.90; p<0.05). This was even more pronounced in younger (<or=60 years) patients (Hp1 allele frequency 0.539). Concomitant asymptomatic lacunar lesions were present in 82 patients, extensive white matter lesions in 47 patients. The association between Hp1 and lacunar stroke suggests that Hp may serve different functions depending on the pathological processes in various types of vascular disease in different organs. The association between Hp1 and lacunar stroke may relate to blood-brain barrier dysfunction, to the association between hypertension and cerebral small vessel disease, or a special dependence of small vessel wall integrity on Hp2-2 related angiogenic potential. The presence of concomitant signs of cerebral small vessel disease weakened the association between Hp1 and lacunar stroke, which could reflect a difference in underlying vascular pathophysiology in which Hp phenotype may play a different role.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691072     DOI: 10.2174/156720208785425675

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  20 in total

Review 1.  The clinical manifestations and pathophysiology of cerebral small vessel disease.

Authors:  Ai-Juan Zhang; Xin-Jun Yu; Mei Wang
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

2.  The Risk of Coronary Heart Disease Associated With Glycosylated Hemoglobin of 6.5% or Greater Is Pronounced in the Haptoglobin 2-2 Genotype.

Authors:  Leah E Cahill; Majken K Jensen; Stephanie E Chiuve; Hadar Shalom; Jennifer K Pai; Alan J Flint; Kenneth J Mukamal; Kathryn M Rexrode; Andrew P Levy; Eric B Rimm
Journal:  J Am Coll Cardiol       Date:  2015-10-20       Impact factor: 24.094

3.  Haptoglobin genotype modulates the relationships of glycaemic control with cognitive function in elderly individuals with type 2 diabetes.

Authors:  Elizabeth Guerrero-Berroa; Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Andrew Levy; Derek Leroith; Michal S Beeri
Journal:  Diabetologia       Date:  2015-01-28       Impact factor: 10.122

Review 4.  New and emerging biomarkers in cardiovascular disease.

Authors:  Leah E Cahill; Monica L Bertoia; Sarah A Aroner; Kenneth J Mukamal; Majken K Jensen
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

5.  Ethnicity/culture modulates the relationships of the haptoglobin (Hp) 1-1 phenotype with cognitive function in older individuals with type 2 diabetes.

Authors:  Elizabeth Guerrero-Berroa; Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Hadas Hoffman; Rachel Preiss; Keren Koifmann; Lior Greenbaum; Andrew Levy; Jeremy M Silverman; Derek Leroith; Mary Sano; Michal Schnaider-Beeri
Journal:  Int J Geriatr Psychiatry       Date:  2015-09-21       Impact factor: 3.485

6.  Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.

Authors:  Tina Costacou; Aaron M Secrest; Robert E Ferrell; Trevor J Orchard
Journal:  Diab Vasc Dis Res       Date:  2014-07-03       Impact factor: 3.291

7.  Analysis of the neuroprotective effect of GLP-1 receptor agonist peptide on cerebral ischemia-reperfusion injury by Quantitative Proteomics Mass Spectrometry.

Authors:  Ying Li; Min Gong
Journal:  Brain Behav       Date:  2021-05-21       Impact factor: 2.708

8.  Haptoglobin 1-1 genotype is associated with poorer cognitive functioning in the elderly with type 2 diabetes.

Authors:  Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Elizabeth Guerrero-Berroa; Mary Sano; Rachel Preiss; Keren Koifman; Hadas Hoffman; Andrew Levy; Jeremy M Silverman; Michal Schnaider-Beeri
Journal:  Diabetes Care       Date:  2013-08-29       Impact factor: 19.112

9.  Plasma haptoglobin concentrations are elevated in patients with coronary artery disease.

Authors:  Ching-Wei Lee; Chin-Wei Lee; Tsai-Mu Cheng; Chih-Pei Lin; Ju-Pin Pan
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

10.  Haptoglobin 2-2 genotype is not associated with cardiovascular risk in subjects with elevated glycohemoglobin-results from the Bruneck Study.

Authors:  Raimund Pechlaner; Stefan Kiechl; Peter Willeit; Egon Demetz; Margot Haun; Siegfried Weger; Friedrich Oberhollenzer; Florian Kronenberg; Enzo Bonora; Günter Weiss; Johann Willeit
Journal:  J Am Heart Assoc       Date:  2014-05-16       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.